Leaders of Triad health care systems ask for help from the community
The leaders of the Triad's three largest health care systems came together Monday to urge the community to help stop the spread of COVID-19.
Vaccines
Omicron will cause more infections but lower hospital rates, analysis shows
University of Washington research predicts the omicron wave will infect more than 400,000 people a day in the U.S. when it crests in about six weeks.
New funding announced to support access to COVID-19 vaccines
North Carolina has announced the next round of funding aimed at ensuring an equitable response to the COVID-19 pandemic.
What the U.S. can — and cannot — do for vaccine equity per the State Department
The U.S. has pledged to deliver 1.1 billion doses of COVID vaccines to countries in need. Billions more are needed. NPR interviewed the State Department's global vaccine coordinator to learn more.
The U.S. is ready to roll out the COVID vaccine once it's approved for kids age 5-11
The White House says the U.S. has enough doses for the country's 28 million kids age 5 to 11 and has laid out a plan to get them inoculated as soon as the vaccine is authorized for the age group.
Cone Health is ready to resume normal surgical procedures
Cone Health is planning a return to normal surgical schedules by the end of October. This comes as the number of people hospitalized for COVID-19 has declined.
Pelosi's trip to Rome was disrupted by violent anti-vaccine mandate protests
House Speaker Nancy Pelosi had to be escorted from a Mass in Rome on Saturday after major protests against Italy's new vaccine mandates broke out.
YouTube Is Banning All Content That Spreads Vaccine Misinformation
The site announced that videos that contain vaccine misinformation will be removed.
Johnson & Johnson Says Its Booster Shot Provides Increased Protection From COVID-19
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
COVID Vaccine For Kids Ages 5 To 11 Is Safe And Effective, Pfizer Says
Pfizer and BioNTech say that early trial results show their vaccine established a strong antibody response against the coronavirus. FDA review is still needed.